DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hydrocortisone (Hydrocortisone Topical) - Hyponatraemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hyponatraemia (16)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) where reactions include hyponatraemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Methotrexate Sodium
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Hydrocortisone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Hydrocortisone side effects in 10 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05

Patient: 10 year old female

Reactions: Cushingoid, Abdominal Pain, Coagulopathy, Hyponatraemia, Hyperviscosity Syndrome, Headache, Pallor, Somnolence, Hepatic Enzyme Increased, Malaise, Nervous System Disorder, Oedema, Asthenia, Hypertriglyceridaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
    Dosage: 8 mg/m2, per day
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: 30 mg, unk
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 10000 iu/m2, per day
    Indication: Acute Lymphocytic Leukaemia

Prednisone
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Epirubicin; Methotrexate; Cytarabine; Daunorubicin HCL; Methotrexate W / Cytarabine / Hydrocortisone; Vincristine; Cyclophosphamide; Mercaptopurine



Possible Hydrocortisone side effects in 18 year old male

Reported by a physician from United States on 2012-05-10

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24



Possible Hydrocortisone side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-04-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-25
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Hydrocortisone side effects in 10 year old female

Reported by a physician from United States on 2012-04-05

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Headache, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Rash Pustular, Back Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Hypophosphataemia, Respiratory Tract Infection, Neuralgia, Enterocolitis Infectious

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29



Possible Hydrocortisone side effects in 18 year old male

Reported by a physician from United States on 2012-04-03

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: White Blood Cell Count Decreased, Abdominal Pain, Metabolic Acidosis, Clostridium Test Positive, Urine Output Decreased, Hypotension, Hyponatraemia, Capillary Leak Syndrome, Platelet Count Decreased, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Oncaspar
    Dosage: 2500 iu;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Doxorubicin HCL
    Dosage: 60 mg/m**2;x1;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Velcade
    Dosage: 1.3 mg/m**2; qd; iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Vincristine
    Dosage: 1.5 mg/m**2;qd;iv
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Prednisone TAB
    Dosage: 20 mg/m**2;qd;po
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Cytarabine
    Dosage: 70 mg;x1;inth
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-02-24

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: inth
    Indication: Acute Lymphocytic Leukaemia



Possible Hydrocortisone side effects in 18 year old male

Reported by a consumer/non-health professional from United States on 2012-03-13

Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-02-24

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Cytarabine
    Dosage: 70 mg, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24

Pegaspargase
    Dosage: 2500 iu, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-02

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-02-24
    End date: 2012-03-04

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia



Possible Hydrocortisone side effects in 10 year old female

Reported by a consumer/non-health professional from United States on 2012-03-09

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Abdominal Pain, Confusional State, Lung Infection, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Clostridial Infection, Back Pain, Rash Pustular, Vomiting, Nausea, Pain in Extremity, Lung Neoplasm, Hypotension, Febrile Neutropenia, Pancytopenia, Hyponatraemia, Hypophosphataemia, Diarrhoea, NO Therapeutic Response, Sepsis, Hypophagia, Respiratory Tract Infection, Enterocolitis Infectious, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Prednisone
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17



Possible Hydrocortisone side effects in female

Reported by a physician from Germany on 2012-02-22

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Headache, Horner's Syndrome, Haematemesis, Metastasis, Electrolyte Imbalance, Thrombocytopenia, Epistaxis, Back Pain, Vomiting, Adrenocortical Insufficiency Acute, Nausea, Anaemia, Neutropenic Sepsis, Hyponatraemia, Pancytopenia, Neoplasm Malignant, Disturbance in Attention, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Hydrocortisone
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2008-12-15

Cisplatin
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-23
    End date: 2011-03-25

Morphine

Som230
    Dosage: 60 mg, unk
    Indication: Neuroendocrine Tumour
    Start date: 2010-06-15
    End date: 2011-01-26

Voltaren
    Dosage: unk
    Start date: 2011-02-01

Etoposide
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-25
    End date: 2011-03-25

Other drugs received by patient: Zoledronic; Astonin-H



Possible Hydrocortisone side effects in 10 year old female

Reported by a physician from United States on 2012-01-24

Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)

Reactions: Back Pain, Rash Pustular, Abdominal Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Hypophosphataemia, Fungaemia, Hypoxia, Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-17

Prednisone TAB
    Dosage: 20 mg/m2, cyclic
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-27

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-29

Pegaspargase
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-15
    End date: 2011-12-29

Methotrexate
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Doxorubicin HCL
    Dosage: 60 mg/m2, cyclic
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2011-12-14
    End date: 2011-12-14

Cytarabine
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29

Hydrocortisone
    Dosage: unk
    Indication: B Precursor Type Acute Leukaemia
    End date: 2011-12-29



Possible Hydrocortisone side effects in 15 year old male

Reported by a physician from United States on 2011-11-29

Patient: 15 year old male

Reactions: Oral Pain, Dehydration, Hyponatraemia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Indication: Acute Lymphocytic Leukaemia

Dasatinib
    Dosage: 7000 milligram;
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Vincristine Sulfate
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Prednisone TAB
    Indication: Acute Lymphocytic Leukaemia

Mercaptopurine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Etoposide

Cytarabine
    Indication: Acute Lymphocytic Leukaemia



Possible Hydrocortisone side effects in 15 year old male

Reported by a consumer/non-health professional from United States on 2011-11-21

Patient: 15 year old male, weighing 56.0 kg (123.2 pounds)

Reactions: Oral Pain, Dehydration, Hyponatraemia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: last administered date:10/07/2011, last dose:10/jul/2011.
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Mercaptopurine
    Dosage: last administered date:20/06/2011,last dose:20/june/2011.
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Methotrexate
    Dosage: last administered date:06/07/2011,last dose:06/jul/2011.
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-14

Dasatinib
    Dosage: last administered date:02/aug/2011.last dose:02/aug/2011.60mg/m2.
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Cytarabine
    Dosage: last administered date:06/07/2011.
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Etoposide
    Dosage: last dose:10/jul/2011, last administered:10/07/2011.
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2011-09-14

Vincristine Sulfate
    Dosage: last administered date:06/07/2011, last dose:06/jul/2011.
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14

Etoposide
    Dosage: last administered date:10/07/2011
    Start date: 2011-09-14

Prednisone TAB
    Dosage: last administered date:10/07/2011,last dose:10/jul/2011.
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-09-14



Possible Hydrocortisone side effects in female

Reported by a physician from Germany on 2011-11-17

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Headache, Horner's Syndrome, Haematemesis, Metastasis, Electrolyte Imbalance, Thrombocytopenia, Epistaxis, Back Pain, Vomiting, Nausea, Adrenocortical Insufficiency Acute, Neutropenic Sepsis, Anaemia, Hyponatraemia, Pancytopenia, Neoplasm Malignant, Disturbance in Attention, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-23
    End date: 2011-03-25

Som230
    Dosage: 60 mg, unk
    Indication: Neuroendocrine Tumour
    Start date: 2010-06-15
    End date: 2011-01-26

Morphine

Etoposide
    Dosage: unk
    Indication: Neoplasm Malignant
    Start date: 2011-03-25
    End date: 2011-03-25

Hydrocortisone
    Dosage: 3 mg, unk
    Administration route: Oral
    Start date: 2008-12-15

Voltaren
    Dosage: unk
    Start date: 2011-02-01

Other drugs received by patient: Astonin-H; Zoledronic



Possible Hydrocortisone side effects in female

Reported by a physician from Germany on 2011-11-11

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Headache, Haematemesis, Horner's Syndrome, Metastasis, Electrolyte Imbalance, Thrombocytopenia, Epistaxis, Back Pain, Vomiting, Nausea, Adrenocortical Insufficiency Acute, Anaemia, Pancytopenia, Hyponatraemia, Neoplasm Malignant, Disturbance in Attention, Hypertension

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Diclofenac Sodium
    Dosage: unk
    Start date: 2011-02-01

Som230
    Dosage: 60 mg, unk
    Indication: Neuroendocrine Tumour
    Start date: 2010-06-15
    End date: 2011-02-01

Hydrocortisone

Morphine

Other drugs received by patient: Astonin-H; Zoledronic

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017